Show an ad over header. AMP

I am the FIRST

CRISPR co-discoverer: How gene editing could help fight future pandemics

The coronavirus pandemic is accelerating the development of CRISPR-based tests for detecting disease — and highlighting how gene-editing tools might one day fight pandemics, one of its discoverers, Jennifer Doudna, tells Axios.

Why it matters: Testing shortages and backlogs underscore a need for improved mass testing for COVID-19. Diagnostic tests based on CRISPR — which Doudna and colleagues identified in 2012, ushering in the"CRISPR revolution" in genome editing —are being developed for dengue, Zika and other diseases, but a global pandemic is a proving ground for these tools that hold promise for speed and lower costs.


Driving the news: Last week, the NIH awarded $250 million for the development of COVID-19 diagnostic tests to a handful of companies, including Mammoth Biosciences, which is working on a CRISPR-based test that CEO Trevor Martin says will deliver 200 tests per hour per machine.

  • Another CRISPR-based test, developed by Sherlock Biosciences and CRISPR pioneer Feng Zhang, received an emergency use authorization (EUA) from the Food and Drug Administration in May — the agency's first for any CRISPR-based technology. (Mammoth has since received an EUA for another CRISPR-based test.)
  • "In a way, the timing of the pandemic coincided with this technology being ready to address this emerging need," says Doudna, a co-founder of Mammoth and a biochemist at UC Berkeley.
  • Of note: UC Berkeley and The Broad Institute of MIT and Harvard, where Zhang is a professor, are in a years-long patent battle over the use of CRISPR in human cells, with potentially billions of dollars from licensing the technology at stake.

The challenge now is "getting it into a format where it can be used easily either in a laboratory or at the point-of-care," like the doctor's office or home, she says.

How it works: Clustered Regularly Interspaced Short Palindromic Repeats, or CRISPR, are sequences of genetic code that bacteria naturally use to find and destroy viruses.

  • Diagnostic tests work by programming CRISPR to search for a particular stretch of RNA or DNA in a virus. If thepathogen is found, enzymes guided by the CRISPR sequence put out a signal.
  • CRISPR can also lead enzymesto a gene that the enzyme then precisely snips or edits, turning it on or off or changing its function.

That editing ability is viewed as having vast potential for treating disease, a nascent use of CRISPR.

  • Earlier this summer, researchers announced that a CRISPR-based therapy appeared to be effective in treating a woman with sickle cell anemia, NPR reported.
  • The approach, in which cells are removed from the body, edited and reinfused via a bone marrow transplant, is expensive. (Gene therapy for a related blood disorder costs about $1.8 million for the treatment alone.)
  • Efficiently delivering CRISPR directly to cells in the body could drive down the cost, says Doudna.

But there's a persistent problem: Getting the sizable CRISPR system through the membranes and to the DNA of the cells that need editing.

  • That's "the bleeding edge" of the field, says Doudna, whose team and others are trying to solve the delivery challenges.
  • Last month, they reported finding a compact form of CRISPR in a virus that infects bacteria. Doudna suspects its small size may make it easier to get it into cells.

And, there are other concerns about off-target editing with currently available enzymes and unknown long-term effects of gene editing directly in the body.

The intrigue: CRISPR could one day be wielded in future pandemics.

  • Some researchers propose it could be used to attack viruses like SARS-CoV-2.
  • Orit might be possible to one day edit immune cells in the body so they are less susceptible to becoming exhausted by a disease, Doudna says.

Yes, but: That would require sophisticated understanding of how a virus changes and the immune system's complex response to it.

  • Some of those questions could be unraveled using machine learning to determine the consequences of perturbing a particular gene in a specific tissue, Doudna says.
  • And if researchers can determine which regions of genetic material in a virus or bacteria don't change over time, CRISPR could be used to program immune cells to recognize those regions and be ready for a type of virus before it shows up, she says, pointing to the use of CRISPR to prime the immune system to attack cancer.

The big picture: Such "genetic vaccination" is a long way off, but it could eliminate having to wait until a virus shows up, make a vaccine to that virus and then vaccinate people, she says.

  • Each year, the influenza vaccine's makeup involves anticipating which strains may be most prevalent by studying the virus' proteins.
  • "I sort of imagine a day we could do that at the genetic level," Doudna says.

Justice Department drops lawsuit against John Bolton over Trump book

The Justice Department on Wednesday dropped its lawsuit against President Trump's former national security adviser John Bolton over the publication of his tell-all book, “The Room Where it Happened.”

Why it matters: The move comes a year after the Trump administration sued Bolton in federal court, claiming he breached his contract by failing to complete a pre-publication review for classified information.

Keep reading... Show less

Fed may raise rates sooner, as inflation is higher than expected

The Federal Reserve kept rates unchanged at its latest policy meeting,but a shift in sentiment emerged as to how soon it should begin raising rates.

Why it matters: The Fed's rock bottom rates policy and monthly asset purchases helped the U.S. markets avoid a meltdown during the COVID crisis last year. But as the economy recovers, a chorus is growing for the Fed to at least consider a timeline for pulling back its support before things get overheated.

Keep reading... Show less

Naftali Bennett: How Israel's new PM plans to handle relations with Biden

New Israeli Prime Minister Naftali Bennett is signaling he intends to move cautiously at first on issues like Iran and the Israeli-Palestinian conflict, an approach that will suit the Biden administration just fine.

Why it matters: Bennett is aiming to avoid an early confrontation with the U.S., and his fragile and ideologically diverse government will have a hard time taking any groundbreaking steps on foreign policy in the first place.

Keep reading... Show less

Biden: Consequences for Russia would be "devastating" if opposition leader Navalny dies

President Biden said he warned Russian President Vladimir Putin during Wednesday's summit that if jailed Russian opposition leader Alexei Navalny dies in prison, the consequences "would be devastating for Russia."

Why it matters: Although the White House had previously warned the Russian government over Navalny's imprisonment, Biden personally delivered the message to Putin on Wednesday.

Keep reading... Show less

Republican Leader Kevin McCarthy will support Juneteenth bill

House Republican Leader Kevin McCarthy will support a bill to make Juneteenth a federal holiday when it comes to the floor later Wednesday, his office tells Axios.

Why it matters: The House is slated to pass a bill making June 19 — Juneteenth — a federal holiday that memorializes when the last enslaved people in Texas learned about their freedom under the Emancipation Proclamation.

  • It will then go to President Biden for his signature just days before the occasion and one day after the Senate passed the bill unanimously.

Biden says he raised human rights issues in Putin summit

President Biden said he raised issues including nuclear arms control, cybersecurity, election interference and violations of human rights in Russia in his meeting with Vladimir Putin in Geneva on Tuesday.

What he's saying: "My agenda is not against Russia or anybody else. It's for the American people," Biden said at a press conference following the summit, which was shorter than expected.

Keep reading... Show less

Putin calls talks with Biden "constructive," says ambassadors will return to posts

Russian President Vladimir Putin of Russia said Wednesday that his summit with President Biden was "constructive," and that the countries had agreed their ambassadors would imminently return to their posts in Moscow and Washington.

What he's saying: "Many of our joint positions are divergent but nevertheless I think both sides manifested a determination to try and understand each other and try and converge our positions," Putin told reporters at a press conference immediately following the meetings.

Keep reading... Show less

Southwest heat wave intensifies, 40 million likely to see 100-degree temperatures

A punishing and long-enduring heat wave is intensifying in parts of the West and Southwest, with heat warnings and advisories in effect across seven states Wednesday. The heat will not relent until late in the weekend.

Threat level: In the coming days, 40 million are likely to see temperatures reach or exceed 100 degrees.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories